AKT1 and squamous cell lung carcinoma: A recent report showed that palbociclib, but not ribociclib, modulates the autophagy pathway and AKT signaling in squamous cell lung carcinoma (Sumi et al., 2015), which correlates with the autophagy induction by palbociclib in HCC found in this report.